AUM Biotech specializes in advanced RNA silencing technologies, particularly through their proprietary AUM silence platform. This technology enables efficient knockdown of various RNA types, including mRNA, microRNA (miRNA), and long non-coding RNA (lncRNA), without the need for transfection reagents. The AUM silence oligos are designed for high sequence specificity and binding affinity, making them a superior alternative to traditional methods like siRNA and shRNA. They are non-toxic and can be utilized in both in vitro and in vivo studies, allowing researchers to work with a wide range of cell types, including difficult-to-transfect primary cells and sensitive patient samples.

In addition to mRNA knockdown, AUM Biotech offers specialized products such as AUM antagomir for miRNA inhibition and AUM lnc for lncRNA knockdown. These products are characterized by their self-delivery capabilities, which eliminate the need for additional delivery vehicles or extensive optimization processes. The AUM silence technology is not only cost-effective but also time-saving, providing researchers with a straightforward protocol that enhances the efficiency of RNA silencing studies. This innovative approach has garnered recognition within the scientific community, contributing to various research publications and NIH grants.

United States

AUM BioTech is a Philadelphia based biotechnology company that offers next-generation genetic research tools in the area of gene silencing and regulation. AUM's products are globally being used by biomedical scientists and researchers working on basic, transitional and pre-clinical research. 

We invite you to speak with our scientific team to discuss your research needs. Book a web meeting today:

https://calendly.com/d/2r6-y62-b7h/invitation-for-rna-silencing-scientific-consultation

AUM Biotech

Company Details